Bericht zu den Digitalen Workshops am 25. September und 2. Oktober 2020

Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.Peer Reviewe

High-Resolution SMAP-Derived Root-Zone Soil Moisture Using an Exponential Filter Model Calibrated per Land Cover Type

Root-zone soil moisture (RZSM) plays a key role for most water and energy budgets, as it is particularly relevant in controlling plant transpiration and hydraulic redistribution. RZSM data is needed for a variety of different applications, such as forecasting crop yields, improving flood predictions and monitoring agricultural drought, among others. Remote sensing provides surface soil moisture (SSM) retrievals, whose key advantage is the large spatial coverage on a systematic basis. This study tests a simple method to retrieve RZSM estimates from high-resolution SSM derived from SMAP (Soil Moisture Active Passive). A recursive exponential filter using a time constant τ is calibrated per land cover type, which uses as an intermediate step a long-term ISBA-DIF (Interaction Soil Biosphere Atmosphere—Diffusion scheme) dataset over an area located in Catalonia, NE of Spain. The τ values thus obtained are then used as an input to the same recursive exponential filter, to derive 1 km resolution RZSM estimates from 1 km SMAP SSM, which are obtained from the original data by downscaling to a 1 km resolution, through the DISPATCH (DISaggregation based on a Physical and Theoretical scale CHange) methodology. The results are then validated with scaled in situ observations at different depths, over two different areas, one representative of rainfed crops, and the other of irrigated crops. In general, the estimates agree well with the observations over the rainfed crops, especially at a 10 cm and 25 cm depth. Nash–Sutcliffe (NS) scores ranging between 0.33 and 0.58, and between 0.37 and 0.56 have been found, respectively. Correlation coefficients for these depths are high, between 0.76 and 0.91 (10 cm), and between 0.71 and 0.90 (25 cm). For the irrigated sites, results are poorer (partly due to the extremely high heterogeneity present), with NS scores ranging between −2.57 and 0.16, and correlations ranging between −0.56 and 0.48 at 25 cm. Given the strong correlations and NS scores found in the surface, the sensitivity of the filter to different τ values was investigated. For the rainfed site, it was found, as expected, with increasing τ, increasing NS and correlations with the deeper layers, suggesting a better coupling. Nevertheless, a strong correlation with the surface (5 cm) or shallower depths (10 cm) observed over certain sites indicates a certain lack of skill of the filter to represent processes which occur at lower levels in the SM column. All in all, a calibration accounting for the vegetation was shown to be an adequate methodology in applying the recursive exponential filter to derive the RZSM estimates over large areas. Nevertheless, the relative shallow surface at which the estimates correlate in some cases seem to indicate that an effect of evapotranspiration in the profile is not well captured by the filter.This research was funded by the Torrres Quevedo program of the Spanish Science Ministry, MICINN (grant number PTQ-16-08766)

H0LiCOW XII. Lens mass model of WFI2033-4723 and blind measurement of its time-delay distance and H0H_0

We present the lens mass model of the quadruply-imaged gravitationally lensed quasar WFI2033-4723, and perform a blind cosmographical analysis based on this system. Our analysis combines (1) time-delay measurements from 14 years of data obtained by the COSmological MOnitoring of GRAvItational Lenses (COSMOGRAIL) collaboration, (2) high-resolution $\textit{Hubble Space Telescope}$ imaging, (3) a measurement of the velocity dispersion of the lens galaxy based on ESO-MUSE data, and (4) multi-band, wide-field imaging and spectroscopy characterizing the lens environment. We account for all known sources of systematics, including the influence of nearby perturbers and complex line-of-sight structure, as well as the parametrization of the light and mass profiles of the lensing galaxy. After unblinding, we determine the effective time-delay distance to be $4784_{-248}^{+399}~\mathrm{Mpc}$, an average precision of $6.6\%$. This translates to a Hubble constant $H_{0} = 71.6_{-4.9}^{+3.8}~\mathrm{km~s^{-1}~Mpc^{-1}}$, assuming a flat $\Lambda$CDM cosmology with a uniform prior on $\Omega_\mathrm{m}$ in the range [0.05, 0.5]. This work is part of the $H_0$ Lenses in COSMOGRAIL's Wellspring (H0LiCOW) collaboration, and the full time-delay cosmography results from a total of six strongly lensed systems are presented in a companion paper (H0LiCOW XIII).Comment: Version accepted by MNRAS. 29 pages including appendix, 17 figures, 6 tables. arXiv admin note: text overlap with arXiv:1607.0140

Proteostasis During Cerebral Ischemia

Cerebral ischemic is a complex pathology involving a cascade of cellular mechanisms, which deregulate proteostasis and lead to neuronal death. Proteostasis refers to the equilibrium between protein synthesis, folding, transport, and protein degradation. Within the brain proteostasis plays key roles in learning and memory by controlling protein synthesis and degradation. Two important pathways are implicated in the regulation of proteostasis: the unfolded protein response (UPR) and macroautophagy (called hereafter autophagy). Both are necessary for cell survival, however, their over-activation in duration or intensity can lead to cell death. Moreover, UPR and autophagy can activate and potentiate each other to worsen the issue of cerebral ischemic. A better understanding of autophagy and ER stress will allow the development of therapeutic strategies for stroke, both at the acute phase and during recovery. This review summarizes the latest therapeutic advances implicating ER stress or autophagy in cerebral ischemic. We argue that the processes governing proteostasis should be considered together in stroke, rather than focusing either on ER stress or autophagy in isolation

Noninferiority of cetuximab every-2-weeks versus standard once-weekly administration schedule for the first-line treatment of RAS wild-type metastatic colorectal cancer

Abstract Aim This study assessed whether cetuximab 500 mg/m2 administered every 2 weeks (Q2W), when combined with chemotherapy as a first-line (1L) treatment, was noninferior to the approved dose (400 mg/m2 followed by 250 mg/m2 once weekly [Q1W]) for overall survival (OS) in adults with RAS wild-type metastatic colorectal cancer (mCRC). Methods This pooled analysis included patients receiving 1L treatment with cetuximab Q1W or Q2W in combination with chemotherapy from post-authorisation studies with patient-level data available to the sponsor. Baseline characteristics were adjusted with a propensity score using inverse probability of treatment weighting (IPTW). Noninferiority in terms of OS was tested with a noninferiority margin for the hazard ratio (HR) of 1.25 using a Cox proportional hazards regression model. Secondary outcomes were progression-free survival (PFS), overall response rate (ORR) and rates of lung/liver metastases resection and serious adverse events. Results OS time was noninferior in the Q2W cohort (n = 554) compared to the Q1W cohort (n = 763), with a HR after IPTW (95% confidence interval) of 0.827 (0.715–0.956) and median OS times of 24.7 (Q1W) and 27.9 (Q2W) months. There were no major differences in PFS (HR: 0.915 [0.804–1.042]). The odds ratios (ORs) after IPTW for ORR (1.292 [1.031–1.617]) and the rates of lung/liver metastases resection (1.419 [1.043–1.932]) favoured the Q2W regimen. No differences were noted in the occurrence rate of any SAE between groups; the OR after IPTW was 1.089 (0.858–1.382). Conclusions The cetuximab Q2W regimen was noninferior to the Q1W regimen for OS in the 1L treatment of mCRC

Ending cervical cancer: A call to action.

The outlook for elimination of the scourge of cervical cancer is bright, because we now have the tools to achieve this goal. In recent years human papillomavirus (HPV) vaccination in high-income countries has resulted in dramatic decreases in HPV infection and associated cervical disease. If all countries with a substantial burden of disease introduce the vaccine nationally, we can protect the vast majority of women and girls most at risk. For women who are beyond the vaccination target age, progress has been made in screening and treatment for cervical precancer, but we must accelerate this momentum to reduce incidence and mortality worldwide to the very low rates found in wealthier countries. Human and financial resources must be increased and directed to programs that follow best practices and reach all women, including the marginalized or disadvantaged. Seven key actions are recommended. Now is the time for action at national, regional, and global levels

ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia

Gene mutations independent of BCR::ABL1 have been identified in newly diagnosed patients with chronic myeloid leukemia (CML) in chronic phase, whereby mutations in epigenetic modifier genes were most common. These findings prompted the systematic analysis of prevalence, dynamics, and prognostic significance of such mutations, in a clinically well-characterized patient population of 222 CML patients from the TIGER study (CML-V) by targeted next-generation sequencing covering 54 myeloid leukemia-associated genes. In total, 53/222 CML patients (24%) carried 60 mutations at diagnosis with ASXL1 being most commonly affected (n = 20). To study mutation dynamics, longitudinal deep sequencing analysis of serial samples was performed in 100 patients after 12, 24, and 36 months of therapy. Typical patterns of clonal evolution included eradication, persistence, and emergence of mutated clones. Patients carrying an ASXL1 mutation at diagnosis showed a less favorable molecular response to nilotinib treatment, as a major molecular response (MMR) was achieved less frequently at month 12, 18, and 24 compared to all other patients. Patients with ASXL1 mutations were also younger and more frequently found in the high risk category, suggesting a central role of clonal evolution associated with ASXL1 mutations in CML pathogenesis